Literature DB >> 18077545

High prevalence of autoantibodies to muscarinic-3 acetylcholine receptor in patients with juvenile-onset Sjögren syndrome.

Y Nakamura, E Wakamatsu, I Matsumoto, M Tomiita, Y Kohno, M Mori, S Yokota, D Goto, S Ito, A Tsutsumi, T Sumida.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18077545     DOI： 10.1136/ard.2007.072421

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN： 0003-4967            Impact factor:   19.103


× No keyword cloud information.
  13 in total

1.  RORγt antagonist suppresses M3 muscarinic acetylcholine receptor-induced Sjögren's syndrome-like sialadenitis.

Authors:  M Tahara; H Tsuboi; S Segawa; H Asashima; M Iizuka-Koga; T Hirota; H Takahashi; Y Kondo; M Matsui; I Matsumoto; T Sumida
Journal:  Clin Exp Immunol       Date:  2016-10-11       Impact factor: 4.330

Review 2.  The clinical approach to autonomic failure in neurological disorders.

Authors:  Eduardo E Benarroch
Journal:  Nat Rev Neurol       Date:  2014-05-27       Impact factor: 42.937

3.  New epitopes and function of anti-M3 muscarinic acetylcholine receptor antibodies in patients with Sjögren's syndrome.

Authors:  H Tsuboi; I Matsumoto; E Wakamatsu; Y Nakamura; M Iizuka; T Hayashi; D Goto; S Ito; T Sumida
Journal:  Clin Exp Immunol       Date:  2010-08-20       Impact factor: 4.330

4.  Peptide-based ELISAs are not sensitive and specific enough to detect muscarinic receptor type 3 autoantibodies in serum from patients with Sjogren's syndrome.

Authors:  N Roescher; A Kingman; Y Shirota; J A Chiorini; G G Illei
Journal:  Ann Rheum Dis       Date:  2010-05-24       Impact factor: 19.103

5.  Autoantibodies Blocking M3 Muscarinic Receptors Cause Postganglionic Cholinergic Dysautonomia.

Authors:  Jose-Alberto Palma; Achla Gupta; Salvador Sierra; Ivone Gomes; Bhumika Balgobin; Lucy Norcliffe-Kaufmann; Lakshmi A Devi; Horacio Kaufmann
Journal:  Ann Neurol       Date:  2020-09-10       Impact factor: 10.422

6.  Anti-centromere antibody-seropositive Sjögren's syndrome differs from conventional subgroup in clinical and pathological study.

Authors:  Hideki Nakamura; Atsushi Kawakami; Tomayoshi Hayashi; Naoki Iwamoto; Akitomo Okada; Mami Tamai; Satoshi Yamasaki; Hiroaki Ida; Katsumi Eguchi
Journal:  BMC Musculoskelet Disord       Date:  2010-07-01       Impact factor: 2.362

7.  Muscarinic type 3 receptor autoantibodies are associated with anti-SSA/Ro autoantibodies in Sjögren's syndrome.

Authors:  Jian Zuo; Adrienne E G Williams; Yun-Jong Park; Kevin Choi; Annie L Chan; Westley H Reeves; Michael R Bubb; Yun Jong Lee; Kyungpyo Park; Carol M Stewart; Seunghee Cha
Journal:  J Immunol Methods       Date:  2016-07-25       Impact factor: 2.303

Review 8.  Childhood Sjögren syndrome: insights from adults and animal models.

Authors:  Scott M Lieberman
Journal:  Curr Opin Rheumatol       Date:  2013-09       Impact factor: 5.006

9.  Younger patients with primary Sjögren's syndrome are more likely to have salivary IgG anti-muscarinic acetylcholine receptor type 3 antibodies.

Authors:  K Jayakanthan; J Ramya; Santosh Kumar Mandal; P Sandhya; M Gowri; Debashish Danda
Journal:  Clin Rheumatol       Date:  2016-01-26       Impact factor: 2.980

10.  How does age at onset influence the outcome of autoimmune diseases?

Authors:  Manuel J Amador-Patarroyo; Alberto Rodriguez-Rodriguez; Gladis Montoya-Ortiz
Journal:  Autoimmune Dis       Date:  2011-12-13
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.